Prof. Dr. Ahmet GÜL

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases , cilt.28, sa.6, ss.300-304, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

47. Immune modulation as a consequence of SARS-CoV-2 infection

Gelmez M. Y., Öktelik F. B., Tahralı İ., Yılmaz V., Küçüksezer U. C., Akdeniz N., et al.

FRONTIERS IN IMMUNOLOGY , cilt.13, 2022 (SCI-Expanded)

48. Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine.

Oztas M., Bektas M., Karacan I., Aliyeva N., Dag A., Aghamuradov S., et al.

Journal of medical virology , cilt.94, ss.3431-3437, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

49. Course and Prognosis of AA Amyloidosis in Patients with Psoriatic Arthritis: Report of Three Cases from a Single Center Cohort and Review of the Literature.

Bektaş M., Koca N., Ince B., Yalçınkaya Y., Esen B. A., Öcal M. L., et al.

Mediterranean journal of rheumatology , cilt.33, sa.2, ss.185-195, 2022 (Scopus)

50. AMYLOID BURDEN AND ASSOCIATED FACTORS PREDICT HIGHER MORTALITY AND POOR OUTCOME IN FAMILIAL MEDITERRANEAN FEVER-ASSOCIATED AA AMYLOIDOSIS: DATA FROM A TERTIARY REFERRAL AMYLOIDOSIS CENTER WITH 137 PATIENTS

BEKTAŞ M., KOCA N., OĞUZ E., İNCE B., SARI S., ŞENTÜRK N., et al.

ANNALS OF THE RHEUMATIC DISEASES , ss.348, 2022 (SCI-Expanded)

51. SERUM AND URINE GALECTIN-9, IP-10 AND SIGLEC-1 AS BIOMARKERS OF DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Mirioglu S., Cinar S., Uludag O., Gurel E., Varelci S., Ozluk Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1374, 2022 (SCI-Expanded)

52. AMYLOID STORM DEVELOPS IN PATIENTS WITH AA AMYLOIDOSIS AND ASSOCIATED WITH HIGHER AMYLOID BURDEN AND INCREASED MORTALITY

BEKTAŞ M., SARI S., KOCA N., OĞUZ E., İNCE B., YALÇINKAYA Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1001, 2022 (SCI-Expanded)

53. ANTI-FIBROTIC THERAPY IN PROGRESSIVE PULMONARY FIBROSIS ASSOCIATED WITH SYTEMIC SCLEROSIS: CHARACTERISTICS OF SSC-IAH PATIENTS RECEIVING NINTEDANIB AND ADVERS EVENTS DURING TREATMENT

Yalcinkaya Y., Amikishiyev S., Aliyeva N., Artim-Esen B., Gul A., Bingol Z., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1499, 2022 (SCI-Expanded)

54. FAVOURABLE COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS

Aliyeva N., Sari S., Amikishiyev S., Dulundu B. C. Y., Suleymanova V., Telli P., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.976-977, 2022 (SCI-Expanded)

55. VASCULAR EVENTS AND ASSOCIATED FACTORS IN ANCA-ASSOCIATED VASCULITIS: ANALYSIS OF 237 PATIENTS WITH LONG-TERM FOLLOW-UP

BEKTAŞ M., İNCE B., ZARALI S., GÜLSEREN Ü. A., ÜK E., YALÇINKAYA Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1432-1433, 2022 (SCI-Expanded)

56. DEVELOPMENT OF MALIGNANCY IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

BEKTAŞ M., İNCE B., ZARALI S., GÜLSEREN Ü. A., ÜK E., AĞARGÜN B. F., et al.

ANNALS OF THE RHEUMATIC DISEASES , ss.1430-1431, 2022 (SCI-Expanded)

57. DIFFERENCES IN THE CLINICAL SPECTRUM OF HAPLOINSUFFICIENCY OF A20 (HA20) CASES DIAGNOSED DURING ADULTHOOD

Amikishiyev S., Aliyeva N., Bektas M., Koca N., Soltanova L., Yalcinkaya Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1756, 2022 (SCI-Expanded)

58. A Case of Budd-Chiari Syndrome Associated With Antiphospholipid Syndrome Treated Successfully by Transjugular Intrahepatic Portosystemic Shunt

Torun E. S., Erciyestepe M., Yalcinkaya Y., Gul A., Inanc M., Ocal L., et al.

CLINICAL MEDICINE INSIGHTS-CASE REPORTS , cilt.15, 2022 (ESCI)

59. Dipyridamole does not have any additive effect on the prevention of COVID-19 coagulopathy.

Kalayoglu Besisik S., Ozbalak M. M., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.

American journal of blood research , cilt.12, sa.2, ss.54-59, 2022 (Hakemli Dergi) Sürdürülebilir Kalkınma

60. Description of damage in different clusters of patients with antiphospholipid syndrome.

Uludağ Ö., Çene E., Gurel E., Çetin Ç., Bektaş M., Yalçınkaya Y., et al.

Lupus , cilt.31, sa.4, ss.433-442, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. The relationship between serum A proliferation-inducing ligand and B-cell activating factor levels with disease activity and organ involvement in systemic lupus erythematosus.

Sari S., Cinar S., Yalcinkaya Y., Artim-Esen B., Ozluk Y., Gul A., et al.

Lupus , cilt.31, sa.5, ss.555-564, 2022 (SCI-Expanded)

62. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

Mert A., VAHABOĞLU H., ARSLAN F., Batirel A., Saracoglu K. T., Bastug A., et al.

RHEUMATOLOGY INTERNATIONAL , sa.3, ss.457-467, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

63. Budd-Chiari syndrome in Behcet's disease: a retrospective multicenter study

Akyol L., Toz B., Bayindir O., Zengin O., Cansu D., Yigit M., et al.

CLINICAL RHEUMATOLOGY , cilt.41, sa.1, ss.177-186, 2022 (SCI-Expanded)

64. Pure Red Cell Aplasia in IgG4-Related Disease: Successful Treatment With Cyclosporine.

Bektaş M., Ağargün B. F., Torun E. S., Çatma Y., Beşişik S. F., Nalçaci M., et al.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases , cilt.27, sa.8S, 2021 (SCI-Expanded)

65. Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab

ALİBAZ ÖNER F., Kaymaz-Tahra S., Bayindir O., YAZICI A., Ince B., Kalkan K., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , sa.6, ss.1224-1229, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

66. Ankilozan spondilit ve psöriyatik artritte sekukinumab deneyimi: Tek merkezden 44 hastanın analizi

BEKTAŞ M., ÇETİN Ç., YALÇINKAYA Y., ESEN B. A., ÖCAL L., GÜL A., et al.

Ulusal Romatoloji Dergisi , cilt.13, sa.3, ss.116-120, 2021 (Hakemli Dergi)

67. A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls

Ince B., Kamali S., Bektas M., Ogret Y., Savran F., Yalcinkaya Y., et al.

RHEUMATOLOGY INTERNATIONAL , sa.9, ss.1667-1672, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

68. Transient Elastography (fibroscan); As a New Non-invasive Diagnostic Method for Detecting Hepatic Involvement of Amyloidosis

BEKTAŞ M., ÇAVUŞ B., AĞARGÜN B. F., Senkal V., KOCA N., İNCE B., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.73, ss.2306-2308, 2021 (SCI-Expanded, Scopus)

69. Adamantiades-Behcet's disease (Behcet's disease) and COVID-19

Zouboulis C. C., van Laar J. A. M., Schirmer M., Emmi G., Fortune F., Gul A., et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , cilt.35, sa.9, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

70. An Algorithm for the Diagnosis of Behcet Disease Uveitis in Adults

Tugal-Tutkun I., Onal S., Stanford M., AKMAN M., Twisk J. W. R., Boers M., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.29, sa.6, ss.1154-1163, 2021 (SCI-Expanded)

71. NK17 and NKreg responses in patients with active Behcet's uveitis

ESEN F., Kokoglu A., ÇETİN Ç., Turkyilmaz O., AKSU CEYLAN N., ORAY M., et al.

EUROPEAN JOURNAL OF IMMUNOLOGY , ss.315, 2021 (SCI-Expanded)

72. Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach

ÖZEN S., SAĞ E., Ben-Chetrit E., Gattorno M., Gül A., Hashkes P. J., et al.

RHEUMATOLOGY , cilt.60, sa.8, ss.3799-3808, 2021 (SCI-Expanded)

73. Reinfection with SARS-CoV-2 in a kidney transplant recipient

Amikishiyev S., Demir E., Aghamuradov S., Garayeva N., Artan A. S., Gül A., et al.

TRANSPLANT INFECTIOUS DISEASE , cilt.23, sa.4, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

74. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease

Gelmez M. Y., Cinar S., Cetin E., Ozcit-Gürel G., Babuna-Kobaner G., Erdugan M., et al.

IMMUNOLOGY LETTERS , cilt.235, ss.1-8, 2021 (SCI-Expanded)

75. SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY ARTERIAL HYPERTENSION: PREDOMINANCE OF PULMONARY FIBROSIS AS A RISK FACTOR FOR MORTALITY IN A SINGLE CENTER COHORT

Amikishiyev S., Yalcinkaya Y., Aliyeva N., Mammadova K., Artim-Esen B., Gul A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1251-1252, 2021 (SCI-Expanded)

76. CLUSTER ANALYSIS AND COMPARISON OF CUMULATIVE DAMAGE BY DIAPS IN A SINGLE CENTER COHORT OF APS PATIENTS

ULUDAĞ Ö., GÜREL E., ÇETİN Ç., ÇENE E., YALÇINKAYA Y., GÜL A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.636-637, 2021 (SCI-Expanded, Scopus)

77. MORE FREQUENT AND EARLIER HIP INVOLVEMENT IN SPONDYLOARTHRITIS ASSOCIATED WITH FAMILIAL MEDITERRANEAN FEVER

BEKTAŞ M., SARI S., ÇETİN Ç., Dulundu B. C. Y., KOCA N., İNCE B., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.951-952, 2021 (SCI-Expanded)

78. FAVOURABLE SHORT-TERM COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS

Aliyeva N., Dulundu B. C. Y., Amikishiyev S., Aghamuradov S., BEKTAŞ M., Ince B., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.913-914, 2021 (SCI-Expanded)

79. PULMONARY INVOLVEMENT IN A SINGLE CENTER COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Senkal N., Kiyan E., Kocasoy-Orhan E., Demir A., Aydoğan S. M., Yalcinkaya Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1191, 2021 (SCI-Expanded)

80. HYPOGAMMAGLOBULINEMIA IS A SIGNIFICANT RISK FACTOR FOR MORTALITY IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS AND COVID-19

İNCE B., BEKTAŞ M., KOCA N., AĞARGÜN B. F., ZARALI S., Guzey D. Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.912-913, 2021 (SCI-Expanded)

81. EVALUATION OF BASELINE POSITRON EMISSION TOMOGRAPHY IN THE DIAGNOSIS AND ASSESSMENT OF GIANT CELL ARTERITIS

Ince B., Isik E. G., Ozkan Z. G., Yalcinkaya Y., Artim-Esen B., Gul A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1210-1211, 2021 (SCI-Expanded)

82. PERFORMANCES OF DIFFERENT CLASSIFICATION CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS IN A SINGLE CENTER COHORT FROM TURKEY

TORUN E. S., BEKTAŞ E., KEMİK F., BEKTAŞ M., ÇETİN Ç., YALÇINKAYA Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.602-603, 2021 (SCI-Expanded)

83. RETINOL BINDING PROTEIN 4 AS AN ACUTE PHASE REACTANT AND BIOMARKER IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND AMYLOIDOSIS COMPARED TO INFECTIONS

Koca N., Deniz R., Erdugan M., Yalcinkaya Y., Artim-Esen B., Ocal M. L., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1006-1007, 2021 (SCI-Expanded)

84. ANALYSIS OF 5-YEAR HOSPITALIZATION DATA OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DAMAGE IS A RISK FACTOR FOR FREQUENT AND LONGER STAYS

Çetin Ç., Can M. G., Öztaşkın S., Yalçınkaya Y., Gül A., İnanç M., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.604-605, 2021 (SCI-Expanded)

85. Tümör nekrozis faktör-alfa inhibitörü tedavisi gereken aksiyal spondiloartritli kadın hastalarda klinik özellikler ve tedavi sonuçları

YALÇINKAYA Y., PEHLİVAN Ö., HÜSEYİNSİNOĞLU N., ALİYEVA N., AMIKISHIYEV S., ESEN B. A., et al.

Ulusal Romatoloji Dergisi , cilt.13, sa.3, ss.100-106, 2021 (Hakemli Dergi)

86. The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response

Başaran S., Şimşek-Yavuz S., Meşe S., Çağatay A., Medetalibeyoğlu A., Öncül O., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , cilt.105, ss.756-762, 2021 (SCI-Expanded, Scopus)

87. Initial complete blood count score and predicting disease progression in COVID-19 patients.

Ozbalak M. M., Kalayoglu Besisik S., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.

American journal of blood research , cilt.11, sa.1, ss.77-83, 2021 (ESCI) Sürdürülebilir Kalkınma

88. Long-term follow-up of 89 patients with giant cell arteritis: a retrospective observational study on disease characteristics, flares and organ damage

Ince B., Artan S., Yalcinkaya Y., Artim-Esen B., Gül A., Ocal L., et al.

RHEUMATOLOGY INTERNATIONAL , sa.2, ss.439-448, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

89. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.

Uludağ Ö., Bektaş M., Cene E., Sezer M., Sahinkaya Y., Gül A., et al.

Journal of thrombosis and thrombolysis , cilt.51, sa.2, ss.466-474, 2021 (SCI-Expanded)

90. mRNA Expression Levels of NKp30, NKp46, NKG2D, Perforin and Granzyme in the Behcet's Disease

GELMEZ M. Y., ÇINAR S., ÇETİN E., ÖKTELİK F. B., Babuna-Kobaner G., Erdugan M., et al.

TURKISH JOURNAL OF IMMUNOLOGY , cilt.9, sa.2, ss.80-85, 2021 (ESCI)

91. A single center survey study of systemic vasculitis and COVID-19 during the first months of pandemic

Ince B., Bektaş M., Koca N., Ağargün B. F., Zarali S., Güzey D. Y., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , sa.5, ss.2243-2247, 2021 (SCI-Expanded)

92. Initial complete blood count score and predicting disease progression in COVID-19 patients

Ozbalak M. M., Besisik S., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., et al.

AMERICAN JOURNAL OF BLOOD RESEARCH , cilt.11, sa.1, ss.77-83, 2021 (ESCI) Sürdürülebilir Kalkınma

93. Antifosfolipid sendromunda kardiyovasküler risk: Trombotik ve obstetrik hastalık alt gruplarının karşılaştırılması

ULUDAĞ Ö., YALÇINKAYA Y., GÜL A., İNANÇ M., ÖCAL L., ESEN B. A.

Ulusal Romatoloji Dergisi , cilt.12, sa.3, ss.83-87, 2020 (Hakemli Dergi)

94. Monogenic lupus due to spondyloenchondrodysplasia with spastic paraparesis and intracranial calcification: case-based review

KARA B., Ekinci Z., Sahin S., GÜNGÖR M., Gunes A. S., Ozturk K., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.40, sa.11, ss.1903-1910, 2020 (SCI-Expanded)

95. Pulmonary Involvement in a Single Center Cohort of Patients with Systemic Lupus Erythematosus

Senkal N., KIYAN E., Kocasoy-Orhan E., Demir A., AYDOĞAN M., YALÇINKAYA Y., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.72, 2020 (SCI-Expanded)

96. The Correlation Between Pregnancy, Disease Activity and Adverse Pregnancy Outcomesin Patients with Systemic Lupus Erythematosus

ÇETİN Ç., Sivrikoz T. S., Tikiz M. A., TORUN E. S., ZARALI S., YALÇINKAYA Y., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.72, 2020 (SCI-Expanded)

97. The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis

Ozdogan H., UĞURLU S., UYGUNOĞLU U., TÜTÜNCÜ M., Gül A., Akman G., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.45, 2020 (SCI-Expanded)

98. Letter: is pneumococcal vaccination safe during the COVID-19 pandemic?

Deniz R., Cagatay A. A., Gül A.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS , cilt.52, sa.5, ss.919-920, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

99. Ancient familial Mediterranean fever mutations in human pyrin and resistance toYersinia pestis

Park Y. H., Remmers E. F., Lee W., Ombrello A. K., Chung L. K., Zhao Shilei Z. S., et al.

NATURE IMMUNOLOGY , cilt.21, sa.8, ss.857-876, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

100. COVID-19 is a Real Headache!

Bolay H., GÜL A., Baykan B.

HEADACHE , cilt.60, sa.7, ss.1415-1421, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

101. Molecular dynamics simulations provide molecular insights into the role of HLA-B51 in Behcet's disease pathogenesis

Gür M., Golcuk M., Gül A., Erman B.

CHEMICAL BIOLOGY & DRUG DESIGN , cilt.96, sa.1, ss.644-658, 2020 (SCI-Expanded)

102. Common genetic susceptibility loci link PFAPA syndrome, Behcet's disease, and recurrent aphthous stomatitis

Manthiram K., Preite S., Dedeoglu F., DEMİR S., ÖZEN S., Edwards K. M., et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.117, sa.25, ss.14405-14411, 2020 (SCI-Expanded)

103. Genetic Susceptibility Loci for Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA) Syndrome

Manthiram K., Preite S., Dedeoglu F., Demir S., Ozen S., Edwards K., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.72, ss.26-27, 2020 (SCI-Expanded)

104. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus

Mirioğlu Ş., Çınar S., Yazıcı H., Özlük Y., Kılıçaslan I., Gül A., et al.

LUPUS , sa.4, ss.379-388, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

105. Genetics of Behcet's Disease

GÜL A., Wallace G. R.

BEHCET SYNDROME, 2ND EDITION , ss.223-233, 2020 (SCI-Expanded)

106. Treatment of Libman-Sacks endocarditis by combination of warfarin and immunosuppressive therapy

Sonsoz M. R., Tekin R. D., Gül A., Bugra Z., Atilgan D.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.47, sa.8, ss.687-690, 2019 (ESCI)

107. Association of Serum and Urine Levels of TWEAK, MCP-1 and NGAL with Disease Activity in Systemic Lupus Erythematosus

Mirioglu S., ÇINAR S., YAZICI H., GÜL A., Ocal L., İNANÇ M., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded)

108. **Genetic Evidence for Recent Positive Selection of the HLA-B51:01 Allele in the Turkish Population, a Population with a High Prevalence of HLA-B51-Associated Behcet's Disease**

Remmers E., Gül A., Kastnerl D.

ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded)

109. Recommendation on Colchicine Dosing and Definition of Colchicine Resistance/Intolerance in the Management of Familial Mediterranean Fever

ÖZEN S., SAĞ E., Ben-Chetrit E., Gattorno M., Gül A., Hashkes P., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded)

110. Autoimmune haemolytic anaemia and thrombocytopaenia in a single-centre cohort of patients with systemic lupus erythematosus from Turkey: clinical associations and effect on disease damage and survival

Artim-Esen B., Çene E., Sahinkaya Y., Erdugan M., Oguz E., Gül A., et al.

LUPUS , cilt.28, sa.12, ss.1480-1487, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

111. AGBL3 as a Novel Gene Associated with Hereditary Hypocomplementemic Urticarial Vasculitis and Favorable Response to Rituximab

Gül A., Abaci N., Sirma-Ekmekci S.

ARTHRITIS & RHEUMATOLOGY , cilt.71, 2019 (SCI-Expanded)

112. Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018

Aydin S. Z., Robson J. C., Sreih A. G., Hill C., Alibaz-Oner F., Mackie S., et al.

JOURNAL OF RHEUMATOLOGY , cilt.46, sa.9, ss.1198-1201, 2019 (SCI-Expanded)

113. Classification criteria for autoinflammatory recurrent fevers

GATTORNO M., Hofer M., FEDERICI S., VANONI F., BOVIS F., AKSENTIJEVICH I., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.78, sa.8, ss.1025-1032, 2019 (SCI-Expanded)

114. Clinical course of abdominal aortic aneurysms in Behcet disease: a retrospective analysis

Sahutoglu T., Esen B. A., Aksoy M., Kurtoglu M., Poyanli A., Gül A.

RHEUMATOLOGY INTERNATIONAL , cilt.39, sa.6, ss.1061-1067, 2019 (SCI-Expanded)

115. An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor-associated Periodic Fever Syndromes, and Cryopyrin-associated Periodic Syndrome

FEDERICI S., VANONI F., Ben-Chetrit E., CANTARINI L., Frenkel J., GOLDBACH-MANSKY R., et al.

JOURNAL OF RHEUMATOLOGY , cilt.46, sa.4, ss.429-436, 2019 (SCI-Expanded)

116. Management of skin, mucosa and joint involvement of Behcet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behcet's syndrome

LECCESE P., Ozguler Y., Christensen R., Esatoglu S. N., BANG D., BODAGHI B., et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.48, sa.4, ss.752-762, 2019 (SCI-Expanded)

117. Phenotypic variability including Behcet's disease-like manifestations in DADA2 patients due to a homozygous c.973-2A > G splice site mutation

van Well G. T. J., Kant B., van Nistelrooij A., Ekmekci S. S., Henriet S. S. V., Hoppenreijs E., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.6, ss.142-146, 2019 (SCI-Expanded)

118. Pseudodominance of autoinflammatory disease in a single Turkish family explained by co-inheritance of haploinsufficiency of A20 and familial Mediterranean fever

Horita N., Gul A., Aksentijevich I., Kastner D. L., Remmers E. F.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.6, ss.89-92, 2019 (SCI-Expanded)

119. Effect of Interferon alfa-2a Treatment on Adaptive and Innate Immune Systems in Patients With Behcet Disease Uveitis

Albayrak O., Oray M., Can F., Kirimli G. U., Gül A., Tugal-Tutkun I., et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE , cilt.60, sa.1, ss.52-63, 2019 (SCI-Expanded)

120. The association between P selectin glycoprotein ligand 1 gene variable number of tandem repeats polymorphism and risk of thrombosis in Behcet's disease

Cosan F., Oku B., Gedar Totuk O. M., Abaci N., Ustek D., Diz Kucukkaya R., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.21, sa.12, ss.2175-2179, 2018 (SCI-Expanded)

121. Management of major organ involvement of Behcet's syndrome: a systematic review for update of the EULAR recommendations

Ozguler Y., LECCESE P., Christensen R., Esatoglu S. N., BANG D., BODAGHI B., et al.

RHEUMATOLOGY , cilt.57, sa.12, ss.2200-2212, 2018 (SCI-Expanded)

122. Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study

Ben-Chetrit E., GATTORNO M., Gül A., KASTNER D. L., Lachmann H. J., TOUITOU I., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.77, sa.11, ss.1558-1565, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

123. Dynamics of Inflammatory Response in Autoinflammatory Disorders: Autonomous and Hyperinflammatory States

Gül A.

FRONTIERS IN IMMUNOLOGY , cilt.9, 2018 (SCI-Expanded)

124. Non-Aphthous Beginning As an Independent Risk Factor for the Course of Behcet's Disease

Aydin M., Artim-Esen B., Inanc M., Ocal L., Gül A.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

125. The Omeract Core Domain Set for Clinical Trials in Behcet's Syndrome

HATEMİ G., Meara A., ÖZGÜLER Y., DİRESKENELİ R. H., Mahrs A., Shea B., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded)

126. Favourable Response to Rituximab for the Treatment of IgG4-Related Disease: Long-Term Follow-up of 10 Patients Resistant to Glucocorticoids and Immunosuppressives

Oguz E., Dagci G., Erdugan M., Artim-Esen B., Gül A., Ocal L., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded)

127. Classification of Idiopathic Inflammatory Myopathies: Assessment of 123 Patients According to 2017 Acr/EULAR Criteria Followed up By a Single Center from Turkey

Oguz E., Sahin E., Erdugan M., Artim-Esen B., Gül A., Ocal L., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded)

128. IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis

Arthur V. L., Shuldiner E., Remmers E. F., Hinks A., Grom A. A., Foell D., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, sa.8, ss.1319-1330, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

129. 2018 update of the EULAR recommendations for the management of Behcet's syndrome

Hatemi G., CHRISTENSEN R., BANG D., BODAGHI B., Celik A. F., Fortune F., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.77, sa.6, ss.808-818, 2018 (SCI-Expanded)

130. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease

Aeschlimann F. A., Batu E. D., CANNA S. W., GO E., Gül A., HOFFMANN P., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.77, sa.5, ss.728-735, 2018 (SCI-Expanded)

131. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes

DE BENEDETTI F., GATTORNO M., ANTON J., Ben-Chetrit E., Frenkel J., HOFFMAN H. M., et al.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.378, sa.20, ss.1908-1919, 2018 (SCI-Expanded)

132. Ailevi Akdeniz Ateşinde Moleküler Tanı Deneyimi: MEFV Geninde Sık Görülen Mutasyonlar

Coşkunpınar E., Özvarnalı A., Çefle K., PALANDUZ A., GÜL A., Öztürk D., et al.

HASEKİ TIP BÜLTENİ , cilt.56, sa.1, ss.42-49, 2018 (Scopus)

133. Binding stability of peptides on major histocompatibility complex class I proteins: role of entropy and dynamics

Gül A., Erman B.

PHYSICAL BIOLOGY , cilt.15, sa.2, 2018 (SCI-Expanded)

134. Molecular Diagnosis Experience in Familial Mediterranean Fever: The Most Frequent Mutations in the MEFV Gene

Coskunpinar E., Ozvarnali A., Cefle K., Palanduz A., Gül A., Ozturk D., et al.

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI , cilt.56, sa.1, ss.42-49, 2018 (ESCI)

135. ASSESMENT OF ORGAN DAMAGE ACCORDING TO IMACS (INTERNATIONAL MYOSITIS ASSESMENT AND CLINICAL STUDIES) MYOSITIS DAMAGE INDEX IN 92 PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOSITIS

Oguz E., Sahin E., Erdugan M., Esen B. A., Gul A., Ocal L., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.1, 2018 (SCI-Expanded)

136. The important role of non-oral aphthous beginning and demographic factors on poor prognosis of Behcet disease

Dilsen N., Konice M., Aral O., Ocal L., Inanc M., Gul A.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded)

137. IDIOPATHIC INFLAMMATORY MYOPATHIES: CLINICAL CHARACTERISTICS, SURVIVAL AND POOR PROGNOSTIC FACTORS OF 110 PATIENTS FROM TURKEY

Oguz E., Erdugan M., Esen B. A., Gul A., Ocal L., Inanc M.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.1, 2018 (SCI-Expanded)

138. Use of Gevokizumab in Patients with Behcet's Disease Uveitis: An International, Randomized, Double-Masked, Placebo-Controlled Study and Open-Label Extension Study

Tugal-Tutkun I., PAVESIO C., DE CORDOUE A., BERNARD-POENARU O., Gül A.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.26, sa.7, ss.1023-1033, 2018 (SCI-Expanded)

139. Non-aphthous beginning as an independent risk factor for the prognosis of Behcet's disease

Aydin M., Artim-Esen B., Inanc M., Ocal L., Gul A.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded)

140. THE ROLE OF 21-HYDROXYLASE DEFICIENCY IN THE PATHOGENESIS OF BEHCET DISEASE

Gul N., Gül A., Inanc M., Ocal L., Aral O., Alagol F.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.81, sa.1, ss.11-16, 2018 (ESCI)

141. Whole-genome imputation study implicates TLR2 locus variants that confer risk for Behcet's disease by increasing innate immune response against microbes

Remmers F., Takeuchi M., Meguro A., Ombrello M. J., Kirino Y., Horita N., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded)

142. Novel association of human leukocyte antigen class I allele with ocular Behcet's disease by imputation of dense genotype data

Takeuchi M., Remmers E., Meguro A., GÜL A., Kastner D., Mizuki N.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

143. Influence of smoking on the manifestations at the onset and course of Behcet disease

Aydin M., Artim-Esen B., Inanc M., Ocal L., Gul A.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded)

144. GENETIC, EPIGENETIC AND ENVIRONMENTAL FACTORS AND THE VASCULITIS RISK IN THE MEDITERRANEAN

Gül A.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.1, 2018 (SCI-Expanded)

145. The OMERACT core set of domains for outcomes measures in Behcet's syndrome

Meara A., Hatemi G., Ozguler Y., Dreskeneli H., Mahr A., Gul A., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.36, sa.6, 2018 (SCI-Expanded)

146. Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016

Sreih A. G., Alibaz-Oner F., Kermani T. A., Aydin S. Z., Cronholm P. F., Davis T., et al.

JOURNAL OF RHEUMATOLOGY , cilt.44, sa.12, ss.1933-1937, 2017 (SCI-Expanded)

147. International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors

Youngstein T., Hoffmann P., Gül A., Lane T., Williams R., Rowczenio D. M., et al.

RHEUMATOLOGY , cilt.56, sa.12, ss.2102-2108, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

148. Behcet's disease (or syndrome) - an update

Gul A.

REVUE DE MEDECINE INTERNE , cilt.38, 2017 (SCI-Expanded)

149. Developing a Core Set of Outcome Measures for Behcet Disease: Report from OMERACT 2016

Hatemi G., Meara A., Ozguler Y., Direskeneli H., Mahr A., Easley E., et al.

JOURNAL OF RHEUMATOLOGY , cilt.44, sa.11, ss.1750-1753, 2017 (SCI-Expanded)

150. New Autoinflammatory Phenotype Associated with Homozygous AGBL3 Variant

Gül A., Abaci N., Ekmekci S. S.

ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded)

151. Efficacy and Safety of Tofacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Prior Therapies

Tesser J., Gül A., Olech E., Oelke K., Lukic T., Murray C. W., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded)

152. A First-in-Human Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Novel Anti-Interleukin 1 Biologic Agent, Rph-104, in Healthy Subjects

Gül A., Ulker S., Senturk R. S., Turk U. O., GÜRGÜN C., Lavrovsky Y., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded)

153. A20 Haploinsufficiency: Clinical Phenotypes and Disease Course of Patients with This Newly Recognized Autoinflammatory Disease

Aeschlimann F. A., Batu E. D., Go E., Gül A., Hoffmann P. M., Leavis H. L., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.69, 2017 (SCI-Expanded)

154. Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments

ÖZEN S., KONE-PAUT I., Gül A.

SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.47, sa.1, ss.115-120, 2017 (SCI-Expanded)

155. Induced-Pluripotent-Stem-Cell-Derived Primitive Macrophages Provide a Platform for Modeling Tissue-Resident Macrophage Differentiation and Function

Takata K., Kozaki T., Lee C. Z. W., Thion M. S., Otsuka M., Lim S., et al.

IMMUNITY , cilt.47, sa.1, ss.183-204, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

156. Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)

KUEMMERLE-DESCHNER J. B., ÖZEN S., Tyrrell P. N., KONE-PAUT I., GOLDBACH-MANSKY R., Lachmann H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.76, sa.6, ss.942-947, 2017 (SCI-Expanded)

157. Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey.

Artim-Esen B., Sahin S., Çene E., Sahinkaya Y., Barut K., Adrovic A., et al.

The Journal of rheumatology , cilt.44, sa.5, ss.619-625, 2017 (SCI-Expanded)

158. Reply to: Behcet's disease: an MHC-I-opathy?

McGonagle D., Aydin S. Z., Gül A., MAHR A., Direskeneli H.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.35, sa.2, 2017 (SCI-Expanded)

159. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications

OMBRELLO M. J., ARTHUR V. L., REMMERS E. F., Hinks A., TACHMAZIDOU I., Grom A. A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.76, sa.5, 2017 (SCI-Expanded)

160. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome

ÖZEN S., KUEMMERLE-DESCHNER J. B., CIMAZ R., Livneh A., QUARTIER P., KONE-PAUT I., et al.

ARTHRITIS CARE & RESEARCH , cilt.69, sa.4, ss.578-586, 2017 (SCI-Expanded)

161. Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behcet's disease susceptibility

TAKEUCHI M., MIZUKI N., MEGURO A., OMBRELLO M. J., KIRINO Y., SATORIUS C., et al.

NATURE GENETICS , cilt.49, sa.3, ss.438-443, 2017 (SCI-Expanded)

162. Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort.

Omma A., Erer B., KARADAĞ Ö., YILMAZ N., Alibaz-Oner F., YILDIZ F., et al.

Clinical and experimental rheumatology , sa.1, ss.77-82, 2017 (SCI-Expanded)

163. Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study

Tugal-Tutkun I., KADAYIFÇILAR S., Khairallah M., Lee S. C., Ozdal P., Ozyazgan Y., et al.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.25, sa.1, ss.62-70, 2017 (SCI-Expanded)

164. A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behcet's disease in HLA-B(star)51 carriers

TAKEUCHI M., OMBRELLO M. J., KIRINO Y., Erer B., Tugal-Tutkun I., Seyahi E., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.75, sa.12, ss.2208-2211, 2016 (SCI-Expanded)

165. Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behcet's disease

ERER B., TAKEUCHI M., Ustek D., Tugal-Tutkun I., Seyahi E., Ozyazgan Y., et al.

GENES AND IMMUNITY , cilt.17, sa.7, ss.396-399, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

166. A BEHCET'S DISEASE PATIENT WITH PERCARDIAL TAMPONADE RELATED TO RIGHT CORONARY PSEUDOANEURYSM

Erer B., Toz B., Gul A.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded)

167. DENSE GENOTYPING OF IMMUNE-RELATED LOCI IMPLICATES HOST RESPONSES TO MICROBIAL EXPOSURE IN BEHCET'S DISEASE SUSCEPTIBILITY

Takeuchi M., Mizuki N., Meguro A., Ombrello M., Kirino Y., Satorius C., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded)

168. **HOMOZYGOSITY FOR A SINGLE ERAP1 ALLOTYPE GREATLY INCREASES BEHCET'S DISEASE RISK IN HLA-B*51 CARRIERS**

Remmers E. F., Takeuchi M., Ombrello M. J., Kirino Y., Erer B., Tugal-Tutkun I., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded)

169. PET/CT IMAGING IN PATIENTS WITH VASCULAR BEHCET DISEASE

Toz B., Erer B., Ozkan Z. G., Esen B. A., Kamali S., Inanc M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded)

170. IDENTIFYING CORE DOMAINS FOR BEHCET'S SYNDROME TRIALS: AN INTERNATIONAL PHYSICIAN AND PATIENT DELPHI EXERCISE

Meara A., Ozguler Y., Maher A., Direskeneli H., Gul A., Yazici Y., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded)

171. CANAKINUMAB TREATMENT IN BEHCET'S DISEASE PATIENTS WITH NEUROLOGIC OR VASCULAR INVOLVEMENT

Gul A., Demir G. A., Kurtuncu M., Erer B., Sevgi S., Turgay S.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.6, 2016 (SCI-Expanded)

172. a Singlecenter Experience of Rituximab Treatment in 86 Patients with Systemic Lupus Erythematosus

Artim-Esen B., Toz B., Erer B., Kamali S., Gül A., Ocal L., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

173. Microscopic colitis in patients with Takayasu's arteritis: a potential association between the two disease entities.

Kanitez N. A., Toz B., Gulluoglu M., Erer B., Esen B. A., Omma A., et al.

Clinical rheumatology , cilt.35, sa.10, ss.2495-9, 2016 (SCI-Expanded)

174. a Systematic Literature Review on the Treatment of Skin, Mucosa and Joint Involvement of BehcEt's Syndrome Informing the Eular Recommendations for the Management of BehcEt's Syndrome

Leccese P., Ozguler Y., Christensen R., Esatoglu S. N., Bang D., Bodaghi B., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

175. Novel Susceptible Genes for Behcet's Disease Identified By Dense Genotyping of Immune-Related Loci Implicate Host Responses to Microbial Exposure

Takeuchi M., Mizuki N., Meguro A., Ombrello M. J., Kirino Y., Satorius C., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

176. Identifying Core Domains for BehcEt's Syndrome Trials: An International Physician and Patient Delphi Exercise

Meara A., Ozguler Y., Mahr A., Direskeneli H., Gül A., Yazici Y., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

177. PET/CT Imaging in Patients with Vascular Behcet Disease

Toz B., Erer B., Kamali S., Inanc M., Ocal L., Gül A.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded, Scopus)

178. Efficacy and Safety of IL-1 Inhibitors in Amyloidosis Associated with Familial Mediterranean Fever Who Underwent Kidney Transplantation

Toz B., Caliskan Y. K., Erer B., Ocal L., Gül A.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

179. Efficacy of Colchicine and IL-1 Inhibitors in Amyloidosis Associated with Familial Mediterranean Fever: A Retrospective Analysis

Toz B., Tecer S., Oguz E., Erdugan M., Artim-Esen B., Kamali S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

180. Utility of Vascular Findings By PET/CT Scan in the Diagnosis and Activity Assesment of Takayasu Arteritis

Toz B., Ozkan Z. G., Artim-Esen B., Erer B., Kamali S., Gül A., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

181. Pharmacokinetic and Pharmacodynamic Characteristics of Canakinumab in Patients with Periodic Fever Syndromes: Results from a Phase III Pivotal Umbrella Trial

Frenkel J., Anton J., Livneh A., Ben-Chetrit E., Brogans P., Bujan-Rivas S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.68, 2016 (SCI-Expanded)

182. Asia Minor, Genes, and Fever

Gül A.

ACTA PHYSIOLOGICA , cilt.218, ss.2, 2016 (SCI-Expanded)

183. DISEASE CHARACTERISTICS, SURVIVAL ANALYSIS AND MORTALITY IN A SINGLE CENTRE COHORT OF PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

Esen B. A., Pehlivan O., Sahinkaya Y., Yuce T., Kamali S., Gul A., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.4, 2016 (SCI-Expanded)

184. AUTOIMMUNE HEMOLYTIC ANEMIA AND THROMBOCYTOPENIA IN A SINGLE CENTRE COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM TURKEY: CLINICAL ASSOCIATIONS AND EFFECT ON DISEASE DAMAGE AND SURVIVAL

ESEN B., Kamali S., GÜL A., Ocal L., İNANÇ M.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.34, sa.4, 2016 (SCI-Expanded, Scopus)

185. Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis

WINTHROP K. L., PARK S., Gül A., CARDIEL M. H., GOMEZ-REINO J. J., TANAKA Y., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.75, sa.6, ss.1133-1138, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

186. Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)

Demirkaya E., Acikel C., Hashkes P., Gattorno M., Gül A., Ozdogan H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.75, sa.6, ss.1051-1056, 2016 (SCI-Expanded)

187. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever

Gül A.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY , cilt.30, sa.2, ss.296-303, 2016 (SCI-Expanded)

188. Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-alpha Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence

Kisacik B., Pamuk O. N., Onat A. M., Erer S. B., Hatemi G., Ozguler Y., et al.

JOURNAL OF RHEUMATOLOGY , cilt.43, sa.3, ss.524-529, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

189. Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients

Demir S., Artim-Esen B., Sahinkaya Y., Pehlivan Ö., Alpay-Kanitez N., Omma A., et al.

LUPUS , cilt.25, sa.2, ss.177-184, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

190. MEFV gene p.Met694Val variation is not associated with subacute thyroiditis in Turkish patients

Gul N., Soyluk Ö., Sariman M., Abaci N., Sirma-Ekmekci S., Aral F., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.7, ss.14758-14761, 2016 (SCI-Expanded)

191. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease

ZHOU Q., WANG H., SCHWARTZ D. M., STOFFELS M., PARK Y. H., ZHANG Y., et al.

NATURE GENETICS , cilt.48, sa.1, ss.67-75, 2016 (SCI-Expanded)

192. **HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis**

Ombrello M. J., Remmers E. F., Tachmazidou I., Grom A., Foell D., Haas J., et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.112, sa.52, ss.15970-15975, 2015 (SCI-Expanded)

193. Current Status, Goals, and Research Agenda for Outcome Measures Development in Behcet Syndrome: Report from OMERACT 2014

Hatemi G., Ozguler Y., Direskeneli H., Mahr A., Gul A., Levı V., et al.

JOURNAL OF RHEUMATOLOGY , cilt.42, ss.2436-2441, 2015 (SCI-Expanded)

194. Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12

AYDIN S. Z., DIRESKENELI H., SREIH A., ALIBAZ-ONER F., Gul A., Kamali S., et al.

JOURNAL OF RHEUMATOLOGY , cilt.42, sa.12, ss.2465-2469, 2015 (SCI-Expanded)

195. 'MHC-I-opathy'-unified concept for spondyloarthritis and Behcet disease

McGonagle D., Aydin S. Z., Gül A., Mahr A., Direskeneli H.

NATURE REVIEWS RHEUMATOLOGY , cilt.11, sa.12, ss.731-740, 2015 (SCI-Expanded)

196. Natural killer cells dominate a Th-1 polarized response in Behçet's disease patients with uveitis.

Kucuksezer U. C., Aktas-Cetin E., Bilgic-Gazioglu S., Tugal-Tutkun I., Gül A., Deniz G.

Clinical and experimental rheumatology , cilt.33, sa.6 Suppl 94, 2015 (SCI-Expanded)

197. Natural killer cells dominate a Th-1 polarised response in Behcet's disease patients with uveitis

Kucuksezer U. C., Aktas-Cetin E., Bilgic-Gazioglu S., Tugal-Tutkun I., Gül A., Deniz G.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.6, 2015 (SCI-Expanded)

198. Generation of integration-free induced pluripotent stem cells from a patient with Familial Mediterranean Fever (FMF)

Fidan K., Kavaklioglu G., Ebrahimi A., Ozlu C., Ay N. Z., Ruacan A., et al.

STEM CELL RESEARCH , cilt.15, sa.3, ss.694-696, 2015 (SCI-Expanded)

199. Biologic Agents in Refractory Adult Still's Disease: Better Response Rates and Acceptable Safety with Anakinra and Tocilizumab

Toz B., İNANÇ M., Erer B., ŞENTÜRK N., Kamali S., Ocal L., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

200. Budd-Chiari Syndrome in Behcet's Disease: a Retrospective Multicenter Study

Akyol L., Toz B., Bayndar O., Zengin O., ÜSKÜDAR CANSU D., Yigit M., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

201. Autoimmune Hemolytic Anemia and Thrombocytopenia in a Single Centre Cohort of Patients with Systemic Lupus Erythematosus from Turkey : Clinical Associations and Effect on Disease Damage and Survival

Artim-Esen B., Kamali S., GÜL A., Ocal L., İNANÇ M.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

202. Salivary IL-1 Alpha and IL-1 Beta Levels Are Associated with Oral Mucosal Activity in Behcet's Disease

Kanitez N. A., Toz B., Berktas F., Ergun S., Koray M., Polat N. G., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

203. 'Epistatic interactions between autoimmunity and genetic thrombophilia' Reply

Bakir-Gungor B., Remmers E. F., Meguro A., Mizuki N., Kastner D. L., Gül A., et al.

EUROPEAN JOURNAL OF HUMAN GENETICS , cilt.23, sa.10, ss.1279-1280, 2015 (SCI-Expanded)

204. HA20: A Novel Autoinflammatory Disease Caused By Haploinsufficiency of A20, Encoded By TNFAIP3

Zhou Q., Wang H., Schwartz D. M., Stoffels M., Park Y. H., Zhang Y., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

205. Development and Validation of Diagnostic Criteria for Cryopyrin Associated Periodic Syndromes

Kuemmerle-Deschner J. B., ÖZEN S., Tyrrell P. N., Kone-Paut I., Goldbach-Mansky R., Lachmann H., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

206. High Rate and Bimodal Pattern of Severe Infection in a Selected ANCA Associated Vasculitis Cohort

Aydin E., Toz B., Erer B., Erelel M., Gocmez A., Gül A., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

207. Prenatal diagnosis and postnatal outcome of persistent right ductus arteriosus: a report of three cases

Ekiz A., GÜL A., Uludogan M., Bornaun H.

JOURNAL OF MEDICAL ULTRASONICS , cilt.42, sa.4, ss.571-574, 2015 (SCI-Expanded)

208. Cogan Syndrome: Differential Response to Biologic Agents and Role of PET-CT in the Increased Diagnosis of Aortitis

Toz B., Erer B., Kamali S., Tugal-Tutkun I., Ocal L., GÜL A.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

209. Quality of Life Changes with Canakinumab Therapy in Adults with Colchicine Resistant FMF

Gül A., Ozdogan H., Kasapcopur O., Erer B., Ugurlu S., SEVGI S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded)

210. Lung Damage in ANCA Associated Vasculitis Assessed By Vasculitis Damage Index: Recurrent Pulmonary Infections Have a Significant Contribution

Aydin E., Toz B., Erer B., Kanitez N. A., Erelel M., Gocmez A., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.67, 2015 (SCI-Expanded, Scopus)

211. The perceptions of pediatricians regarding their self-efficacy in child neglect and abuse

Gul H., YÜRÜMEZ E., Yaylali F. H., Gul A.

TURKISH JOURNAL OF PEDIATRICS , cilt.57, sa.5, ss.475-481, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

212. Direct and indirect costs associated with ankylosing spondylitis and related disease activity scores in Turkey

Akkoc N., Direskeneli H., Erdem H., Gül A., KABASAKAL Y., KİRAZ S., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.35, sa.9, ss.1473-1478, 2015 (SCI-Expanded)

213. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever

Gül A., Ozdogan H., Erer B., Ugurlu S., Kasapcopur O., Davis N., et al.

ARTHRITIS RESEARCH & THERAPY , cilt.17, 2015 (SCI-Expanded)

214. Pathogenesis of Beh double dagger et's disease: autoinflammatory features and beyond

Gul A.

SEMINARS IN IMMUNOPATHOLOGY , cilt.37, sa.4, ss.413-418, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

215. A VERY HIGH PREVALANCE OF AVASCULAR NECROSIS IN TURKISH PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS (WEGENER'S): PRELIMINARY RESULTS FROM A SINGLE CENTRE

Toz B., Erer B., Kanitez N. A., Esen B. A., GÜL A., İNANÇ M., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.1110-1111, 2015 (SCI-Expanded)

216. LUNG DAMAGE IN ANCA ASSOCIATED VASCULITIS ASSESSED BY VASCULITIS DAMAGE INDEX: RECURRENT PULMONARY INFECTIONS HAVE A SIGNIFICANT CONTRIBUTION

Aydin E., Toz B., Erelel M., Gocmez A., Erer B., Kanitez N. A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.513, 2015 (SCI-Expanded)

217. MATHEMATICAL MODELING OF BEHCET'S DISEASE: A DYNAMICAL SYSTEMS APPROACH

Erdem C., Bozkurt Y., Erman B., Gül A., Demir A.

JOURNAL OF BIOLOGICAL SYSTEMS , cilt.23, sa.2, ss.231-257, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

218. SALIVARY IL-1 ALPHA AND IL-1 BETA LEVELS ASSOCIATED WITH ORAL MUCOSAL DISEASE ACTIVITY IN BEHCET'S DISEASE

Alpay-Kanitez N., Toz B., Berktas F., Guzel M., Ergun S., Koray M., et al.

ANNALS OF THE RHEUMATIC DISEASES , ss.403-404, 2015 (SCI-Expanded)

219. HIGH RATE AND BIMODAL PATTERN OF SEVERE INFECTION IN A SELECTED ANCA ASSOCIATED VASCULITIS COHORT

Aydin E., Toz B., Erelel M., Erer B., Esen B. A., Gul A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.525-526, 2015 (SCI-Expanded)

220. VALIDITY AND RELIABILITY OF MEDICATION ADHERENCE SCALE IN FMF (ADULT VERSION)

Fidanci B. E., Yesilkaya S., Acikel C., Ozden A., Simsek D., Yildiz F., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.1274-1275, 2015 (SCI-Expanded)

221. Identification of possible pathogenic pathways in Behcet's disease using genome-wide association study data from two different populations

Bakir-Gungor B., Remmers E. F., Meguro A., Mizuki N., Kastner D. L., Gül A., et al.

EUROPEAN JOURNAL OF HUMAN GENETICS , cilt.23, sa.5, ss.678-687, 2015 (SCI-Expanded)

222. Favourable pregnancy outcome in Takayasu arteritis: a single-centre experience

Alpay-Kanitez N., Omma A., Erer B., Artim-Esen B., Gül A., Inanc M., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.33, sa.2, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

223. Anti-interferon alpha antibodies and autoantibodies in patients with Beh double dagger et's disease uveitis treated with recombinant human interferon alpha-2a

Aydinoglu-Candan O., Araz-Ersan B., Gül A., Badur S., Tugal-Tutkun I.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , cilt.253, sa.3, ss.457-465, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

224. Unified Modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes

Bozkurt Y., Demir A., Erman B., Gül A.

COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE , 2015 (SCI-Expanded)

225. The rate and significance of type 1/type 2 serum amyloid A protein gene polymorphisms in patients with ankylosing spondylitis and amyloidosis

ÇETİN G. Y., Ganiyusufoglu E., Solmaz D., Cagatay Y., Oner S. Y., Erer B., et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS , cilt.22, sa.3, ss.207-208, 2015 (SCI-Expanded)

226. Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening

Demir A., Akyuz F., Gokturk S., Evirgen S., Akyuz U., Ormeci A., et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , cilt.49, sa.12, ss.1414-1418, 2014 (SCI-Expanded)

227. Familial Mediterranean fever phenotype and MEFV variations

Gul A.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.6, 2014 (SCI-Expanded)

228. **HLA-DRB1*1101, Regulatory Variants of the MHC, and a Regulatory Region Near an Intergenic Long Noncoding RNA on Chromosome 1 Are Risk Factors for Systemic Juvenile Idiopathic Arthritis.**

Ombrello M. J., Remmers E. F., Tachmazidou I., Grom A., Foell D., Martini A., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded)

229. Evaluation of KIR3DL1/KIR3DS1 Association with Behcet's Disease in Turkish Individuals.

Erer B., Remmers E. F., Takeuchi M., Satorius C., Ustek D., Tugal-tutkun I., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded)

230. Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.

Kisacik B., Pamuk O., Onat A. M., Erer B., Hatemi G., Ozguler Y., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.66, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

231. Genetic susceptibility to Behcet's disease

Gul A.

ORAL DISEASES , cilt.20, ss.2, 2014 (SCI-Expanded)

232. Cluster analysis of autoantibodies in 852 patients with systemic lupus erythematosus from a single center.

Artim-Esen B., Çene E., Sahinkaya Y., Ertan S., Pehlivan O., Kamali S., et al.

The Journal of rheumatology , cilt.41, sa.7, ss.1304-10, 2014 (SCI-Expanded)

233. Increased IL-23 receptor, TNF-alpha and IL-6 expression in individuals with the IL23R-IL12R132 locus polymorphism

Cavus F., Ulusoy C., Orcen A., Gül A., Tuzun E., Vural B.

IMMUNOLOGY LETTERS , cilt.160, sa.1, ss.96-98, 2014 (SCI-Expanded)

234. Impact of rheumatoid arthritis in Turkey: a questionnaire study

Direskeneli H., Akkoc N., Bes C., CAKIR N., ÇEFLE A., Cobankara V., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, ss.477-483, 2014 (SCI-Expanded)

235. Behcet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity

OMBRELLO M. J., KIRINO Y., de Bakker P. I. W., Gül A., KASTNER D. L., REMMERS E. F.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.111, sa.24, ss.8867-8872, 2014 (SCI-Expanded)

236. Does FMF gene exist in multiple sclerosis and contribute to the progression?

Ozaras N., Akman-Demir G., Ustek D., Eraksoy M., Abaci N., Gül A.

NEUROLOGY ASIA , cilt.19, sa.2, ss.235-236, 2014 (SCI-Expanded)

237. Üveitli Behçet Hastalarında Atak Remisyon Dönemi NK İzolasyon Saflıklarının Karşılaştırıması

KÜÇÜKSEZER U. C., TAHRALI İ., BİLGİÇ GAZİOĞLU S., ÇETİN E., GÜL A., Tuğal Tutkun İ., et al.

Deneysel Tıp Dergisi , cilt.3, sa.6, ss.23-28, 2014 (Hakemli Dergi)

238. FMF50: a score for assessing outcome in familial Mediterranean fever

ÖZEN S., Demirkaya E., DÜZOVA A., Erdogan O., ERKEN E., Gül A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.73, sa.5, ss.897-901, 2014 (SCI-Expanded)

239. Treatment of Familial Mediterranean Fever: Colchicine and Beyond

Gul A.

ISRAEL MEDICAL ASSOCIATION JOURNAL , cilt.16, sa.5, ss.281-284, 2014 (SCI-Expanded)

240. Identification of multiple genetic susceptibility loci for Behcet's disease

Takeuchi M., Mizuki N., Meguro A., Tugal-Tutkun I., Ozyazgan Y., Ohno S., et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE , cilt.55, sa.13, 2014 (SCI-Expanded)

241. Effects of Smoking in Patients with Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis Receiving TNF Inhibitors

Pehlivan O., YALÇINKAYA Y., HÜSEYİNSİNOĞLU N., Kanitez N. A., Esen B. A., Erer B., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded)

242. Behcet's Syndrome According to Classical and Population Genetics

Meguro A., Mizuki N., Gül A., Kitaichi N., Ohno S.

BEHCET'S SYNDROME: FROM PATHOGENESIS TO TREATMENT , ss.25-37, 2014 (SCI-Expanded)

243. Genetics of Behcet's disease: lessons learned from genomewide association studies

Gul A.

CURRENT OPINION IN RHEUMATOLOGY , cilt.26, sa.1, ss.56-63, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

244. MEFV gene variations in patients with systemic lupus erythematosus

Erer B., Cosan F., Oku B., Ustek D., Inanc M., Aral O., et al.

MODERN RHEUMATOLOGY , cilt.24, sa.1, ss.93-96, 2014 (SCI-Expanded)

245. Comparative Analysis of Spondyloarthritis (SPA) Associated with Familial Mediterranean Fever (FMF) and Behcet Disease (BD): 50 Year-Experience

Dilsen N., Konice M., Aral O., Ocal L., Inanc M., Gül A.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)

246. Üvietli Behçet Hastalarında Atak Remisyon Dönemi NK İzolasyon Saflıklarının Karşılaştırılması.

KÜÇÜKSEZER U. C., Tahrali I., Gazioglu S. B., ÇETİN E., GÜL A., Tugal-Tutkun I., et al.

Deneysel Tıp Dergisi , cilt.3, sa.6, ss.23-38, 2013 (Hakemli Dergi)

247. Üveitli Behçet Hastalarında Atak-Remisyon Dönemi NK İzolasyon Saflıklarının Karşılaştırılması

KÜÇÜKSEZER U. C., TAHRALI İ., BİLGİÇ GAZİOĞLU S., ÇETİN E., GÜL A., TUTKUN N. İ., et al.

Deneysel Tıp Araştırma Enstitüsü Dergisi , cilt.3, sa.6, ss.23-28, 2013 (Hakemli Dergi)

248. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behcet's disease

Vural B., Sehitoglu E., Cavus F., Yalcinkaya N., Haytural H., Kucukerden M., et al.

JOURNAL OF NEUROIMMUNOLOGY , sa.1-2, ss.139-144, 2013 (SCI-Expanded)

249. INDIRECT COSTS ASSOCIATED WITH ANKYLOSING SPONDYLITIS IN TURKEY

Akkoc N., Direskeneli H., Erdem H., Gul A., Kabasakal Y., Kiraz S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.1029, 2013 (SCI-Expanded)

250. CROSS-SECTIONAL ASSESSMENT OF DAMAGE IN TAKAYASU ARTERITIS WITH A VALIDATED TOOL

Omma A., Erer B., KARADAĞ Ö., YILMAZ N., Oner F. A., YILDIZ F., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.71, ss.224, 2013 (SCI-Expanded)

251. PRODUCTIVITY LOSS DUE TO SICK LEAVE IN PATIENTS WITH ANKYLOSING SPONDYLITIS

Akkoc N., Direskeneli H., Erdem H., Gul A., Kabasakal Y., Kiraz S., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.72, ss.662-663, 2013 (SCI-Expanded)

252. POOR IMMUNIZATION WITH HEPATITIS B VACCINATION IN PATIENTS WITH GRANULOMATOSIS WITH POLIANGIITIS (WEGENER'S) AND MORE FAVORABLE ANTIBODY RESPONSE IN FEMALES

Kara E., Erer B., Esen B. A., Omma A., Sahinkaya Y., Kanitez N., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.71, ss.385, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

253. ANKYLOSING SPONDYLITIS HEALTH CARE COSTS AND ASSOCIATED DISEASE ACTIVITY SCORES IN TURKEY

Akkoc N., Direskeneli H., Erdem H., Gul A., Kabasakal Y., Kiraz S., et al.

VALUE IN HEALTH , cilt.16, sa.3, 2013 (SCI-Expanded)

254. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease

Kirino Y., Zhou Q., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.110, sa.20, ss.8134-8139, 2013 (SCI-Expanded)

255. A novel TNFRSF1 gene mutation in a Turkish family: a report of three cases

Cosan F., YAZICI A., Yilmazer B., Gül A., Ustek D., ÇEFLE A.

CLINICAL RHEUMATOLOGY , cilt.32, 2013 (SCI-Expanded)

256. Beh‡et's disease: immunological relevance with arthritis of ankylosing spondylitis

Cetin E., Cosan F., Kucuksezer U. C., Bilgic S., Cagatay Y., Gül A., et al.

RHEUMATOLOGY INTERNATIONAL , sa.3, ss.733-741, 2013 (SCI-Expanded)

257. Association of the MEFV Gene Variations With Inflammatory Bowel Disease in Turkey

Akyuz F., Besisik F., Ustek D., Ekmekci C., Uyar A., Pinarbasi B., et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.47, sa.3, 2013 (SCI-Expanded)

258. **Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1**

Kirino Y., Bertsias G., Ishigatsubo Y., Mizuki N., Tugal-Tutkun I., Seyahi E., et al.

NATURE GENETICS , cilt.45, sa.2, ss.202-207, 2013 (SCI-Expanded)

259. Expression of regulatory receptors on γδ T Cells and their cytokine production in Behcet's disease

Parlakgul G., Guney E., Erer B., Kilicaslan Z., Direskeneli H., Gül A., et al.

Arthritis Research and Therapy , cilt.15, sa.1, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

260. INDIRECT COSTS ASSOCIATED WITH ANKYLOSING SPONDYLITIS IN TURKEY

Akkoc N., Direskeneli H., Erdem H., Gul A., Kabasakal Y., Kiraz S., et al.

VALUE IN HEALTH , cilt.15, sa.7, 2012 (SCI-Expanded)

261. Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever

Alpay N., Sumnu A., Caliskan Y., Yazici H., Turkmen A., Gül A.

RHEUMATOLOGY INTERNATIONAL , cilt.32, sa.10, ss.3277-3279, 2012 (SCI-Expanded)

262. Behçet Hastalarında SWAP70 Antikorunun İncelenmesi

uğurel e., karabulut a., GÜL A., güre a. o., TÜZÜN E., ÖZBEK U., et al.

Deneysel Tıp Dergisi , cilt.2, sa.2, ss.22-29, 2012 (Hakemli Dergi)

263. PRODUCTIVITY LOSS OF ANKYLOSING SPONDYLITIS PATIENTS IN TURKEY DUE TO SICK LEAVE

Akkoc N., Hamuryudan V., Durguner B., Direskeneli H., Gul A., Kabasakal Y., et al.

VALUE IN HEALTH , cilt.15, sa.4, 2012 (SCI-Expanded)

264. Investigation of Swap70 antibody in patients with Behcet’s disease

Uğurel E., Karabulut A., Gül A., Güre A., Shugaiv E., Tüzün E., et al.

EXPERIMED , cilt.2, sa.4, ss.22-29, 2012 (Hakemli Dergi)

265. Interleukin-1 beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study

Gül A., Tugal-Tutkun I., Dınarello C. A., Reznıkov L., Esen B. A., Mırza A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.71, ss.563-566, 2012 (SCI-Expanded)

266. **HLA-B*51 and Behcet Disease**

Gül A., Ohno S.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.20, sa.1, ss.37-43, 2012 (SCI-Expanded)

267. Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology

Kamali S., Artim-Esen B., Erer B., Ozdener L., Gül A., Ocal L., et al.

CLINICAL RHEUMATOLOGY , cilt.31, sa.2, ss.325-328, 2012 (SCI-Expanded)

268. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study

Esen B. A., Yilmaz G., Uzun S., Ozdamar M., Aksozek A., Kamali S., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.32, sa.1, ss.79-83, 2012 (SCI-Expanded)

269. Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus.

SAYARLIOGLU M., YUZBASIOGLU N., Inanc M., KAMALI S., CEFLE A., KARAMAN O., et al.

Rheumatology international , cilt.32, ss.177-82, 2012 (SCI-Expanded)

270. Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes

KUEMMERLE-DESCHNER J. B., HACHULLA E., CARTWRIGHT R., Hawkins P. N., TRAN T. A., Bader-Meunier B., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.70, sa.12, ss.2095-2102, 2011 (SCI-Expanded)

271. Familial Mediterranean Fever and Seronegative Arthritis

AKKOÇ N., Gül A.

CURRENT RHEUMATOLOGY REPORTS , cilt.13, sa.5, ss.388-394, 2011 (SCI-Expanded)

272. Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behcet's disease

Vural B., Ugurel E., Tuzun E., Kurtuncu M., Zuliani L., Cavus F., et al.

JOURNAL OF NEUROIMMUNOLOGY , sa.1-2, ss.91-97, 2011 (SCI-Expanded)

273. The regulation of MEFV expression and its role in health and familial Mediterranean fever

Grandemange S., Aksentijevich I., Jeru I., Gul A., Touitou I.

GENES AND IMMUNITY , cilt.12, sa.7, ss.497-503, 2011 (SCI-Expanded)

274. TNF-alpha antagonist therapy modify the tuberculin skin test response

Cagatay T., Kilicaslan Z., Cagatay P., Mertsoylu M., Gulbaran Z., Yildiz R., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.31, sa.9, ss.1147-1151, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

275. Genome-wide association studies in Behcet's disease: expectations and promises

Gul A.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.29, sa.4, 2011 (SCI-Expanded)

276. Comparison of perinatal and maternal outcomes of severe preeclampsia, eclampsia, and HELLP syndrome

Yildirim G., Gungoruduk K., Aslan H., GÜL A., Bayraktar M., Ceylan Y.

JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION , cilt.12, sa.2, ss.90-96, 2011 (ESCI)

277. Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome.

CEFLE A., Inanc M., SAYARLIOGLU M., KAMALI S., Gul A., Ocal L., et al.

Rheumatology international , cilt.31, ss.183-9, 2011 (SCI-Expanded)

278. Association of Familial Mediterranean Fever-Related MEFV Variations With Ankylosing Spondylitis

Cosan F., Ustek D., Oku B., Duymaz-Tozkir J., Cakiris A., Abaci N., et al.

ARTHRITIS AND RHEUMATISM , cilt.62, sa.11, ss.3232-3236, 2010 (SCI-Expanded)

279. Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis

Cagatay T., Aydin M., Sunmez S., Cagatay P., Gulbaran Z., Gül A., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.30, sa.11, ss.1459-1463, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

280. **Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease**

REMMERS E. F., Cosan F., KIRINO Y., OMBRELLO M. J., Abaci N., SATORIUS C., et al.

NATURE GENETICS , sa.8, ss.698-704, 2010 (SCI-Expanded)

281. Recurrent anterior uveitis in Henoch Schonlein's vasculitis

Erer B., Kamali S., Cingu K., Kilicaslan I., Gül A., Inanc M., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.30, sa.10, ss.1377-1379, 2010 (SCI-Expanded)

282. HSP 60 expression in recurrent oral ulcerations of Behcet's disease

Deniz E., Guc U., Buyukbabani N., Gül A.

ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY , cilt.110, sa.2, ss.196-200, 2010 (SCI-Expanded)